Vivos Therapeutics VVOS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 3.10 | 3 | -151.76 | -5 | -20.90 | 26 |
| 2025Q2 | 3.16 | 5 | -111.52 | -5 | -26.87 | 26 |
| 2025Q1 | 2.85 | 4 | -62.52 | -4 | -29.09 | 11 |
| 2024Q4 | 4.29 | 8 | -36.20 | -3 | -18.46 | 15 |
| 2024Q3 | 2.61 | 8 | -37.35 | -3 | -16.78 | 15 |
| 2024Q2 | 2.22 | 6 | -55.68 | -2 | -13.96 | 16 |
| 2024Q1 | 4.83 | 1 | -757.91 | -4 | -33.40 | 12 |
| 2023Q4 | 12.44 | 0 | -1863.89 | -4 | -40.47 | 11 |
| 2023Q3 | 4.80 | 0 | -194.52 | -2 | -17.39 | 10 |
| 2023Q2 | 12.75 | 2 | -121.51 | -6 | -35.84 | 14 |
| 2023Q1 | 8.53 | 7 | -28.88 | -2 | -11.05 | 17 |
| 2022Q4 | 10.05 | 5 | -83.09 | -6 | -37.91 | 14 |
| 2022Q3 | 16.25 | 10 | -44.01 | -5 | -25.41 | 18 |
| 2022Q2 | 32.25 | 15 | -38.97 | -7 | -25.93 | 24 |
| 2022Q1 | 67.00 | 21 | -22.89 | -5 | -16.86 | 30 |
| 2021Q4 | 56.25 | 26 | -25.49 | -7 | -19.79 | 34 |
| 2021Q3 | 101.00 | 32 | -15.82 | -5 | -12.51 | 41 |
| 2021Q2 | 123.75 | 36 | -15.91 | -4 | -11.87 | 46 |
| 2021Q1 | 166.00 | 14 | -21.75 | -3 | -14.38 | 22 |
| 2020Q4 | 147.75 | 17 | -6 | -36.96 | 25 |